News|Articles|October 24, 2024
Tyrvaya® (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease.
Sponsored Content: Overview of dry eye disease pathophysiology and proper administration technique for the Tryvaya nasal spray. Tyrvaya is a registered trademark of Oyster Point Pharma, Inc., a Viatris Company.
Advertisement
Indication
Tyrvaya® (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease.
Important Safety Information
The most common adverse reaction reported is 82% of patients was sneezing. Events that were reported in 5-16% of patients were cough, throat irritation, and instillation-site (nose) irritation.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Oral GLP-1 Medication Will Impact the Patient Medication Journey
2
Maternal Health Awareness Day: Advocacy, Policy Crucial for Protecting Access to Maternal Health
3
Congressional Spending Bill to Include Key PBM Contracting Reform
4
PQA Resource Guide Details Strategic Approaches to SDOH Intervention Success
5